Minimally Invasive vs. Open Pancreatoduodenectomy: Recovery Insights
Minimally invasive pancreatoduodenectomy (mipd) enhances recovery compared to open pancreatoduodenectomy (opd), especially in the month post-surgery.
Newsletter
Every new paper in this field, in your inbox.
Minimally invasive pancreatoduodenectomy (mipd) enhances recovery compared to open pancreatoduodenectomy (opd), especially in the month post-surgery.
Minimally invasive robotic placement of hepatic artery infusion pumps shows promise for recurrent colorectal liver metastasis patients post-hemihepatectomy.
Neoadjuvant chemotherapy's benefit in early-stage pancreatic ductal adenocarcinoma is questionable due to bias in survival estimates.
Laparoscopic anterior-approach right posterior sectionectomy is a safe option for hepatocellular carcinoma tumors over 10 cm.
Surgeons can safely perform a remnant-sparing distal pancreatectomy using fluorescence guidance for select patients with metachronous pancreatic cancer after Whipple procedure.
Optimal treatment timing significantly impacts survival in localized colon, lung, and pancreatic cancers.
Surgeons now have a validated definition of a textbook outcome for distal pancreatectomy, which influences patient selection and post-operative management.
Robotic pancreatoduodenectomy has greater postoperative complication risks than laparoscopic, especially after conversion.
Patients with biological borderline resectable pancreatic cancer and CA19-9 levels ≥500 u/ml show worse outcomes and need tailored surgical approaches.
Postpancreatectomy acute pancreatitis (PPAP) is a key factor increasing mortality after pancreatoduodenectomy.